{"nct_id":"NCT00858234","title":"Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2009-02-13","start_date_type":"ACTUAL","primary_completion_date":"2010-06-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-04-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}